Role of incretin, incretin analogues and dipeptidyl peptidase 4 inhibitors<br /> in the pathogenesis and treatment of diabetes mellitus

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2008, Vol 25, Issue 5

Abstract

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived incretin hormones that stimulate insulin and suppress glucagon secretion, inhibit gastric emptying, and reduce appetite and food intake. An additional action of GLP-1 is the in vitro inhibition of β-cell apoptosis. GLP-1 can significantly lower plasma glucose in the majority of patients with type 2 diabetes. GLP-1 is inactivated rapidly in vivo by dipeptidyl peptidase 4 (DPP-4) and thus does not appear to be useful as a therapeutic agent in the long-term treatment of diabetes. Therapeutic approaches for enhancing incretin action include degradation-resistant GLP-1 receptor agonists, and inhibitors of DPP-4 activity. Clinical trials with the incretin mimetic exenatide and liraglutide show reduction in fasting and postprandial glucose concentration, and HbA1c, associated with weight loss, but also some nausea and, rarely, vomiting. The DPP-4 inhibitors (vildagliptin, sitagliptin, saxagliptin) control elevated blood glucose by promoting pancreatic insulin secretion, suppressing pancreatic glucagon secretion, and reducing glucose production by the liver. The DPP-4 inhibitors have shown clinically significant HbA1c reduction with a low risk of hypoglycemia and no effect on body weight, and the potential, based on animal and in vitro studies, for the regeneration and differentiation of pancreatic β-cells. However, long-term clinical studies are needed to determine the benefits of targeting the incretin axis for the treatment of type 2 diabetes.

Authors and Affiliations

S. PAPAS, A. PAPAZAFIROPOULOU

Keywords

Related Articles

Negative contrast apple-core defect

No abstract available

H ενδογενής PAF-ακετυλοϋδρολάση επηρεάζει την αντιγονικότητα της οξειδωμένης LDL<br /> σε ασθενείς με στεφανιαία νόσο <br /> <br />

ΣΚΟΠΟΣ Η οξειδωτική τροποποίηση της LDL (oxLDL) επάγει τη δημιουργία αντιγονικών επιτόπων, όπως είναι η οξειδωμένη φωσφατιδυλοχολίνη (oxPC), η λυσοφωσφατιδυλοχολίνη (lyso-PC), ο παράγοντας ενεργοποίησης των αιμοπεταλίων...

Percutaneous endoscopic gastrostomy. The clinical experience in the University Hospital of Patras

OBJECTIVE In the past decade percutaneous endoscopic gastroscopy (PEG) has displaced surgical gastrostomy as the method of choice for long-term enteral nutrition. The aim of this study was to present clinical experience...

The British health system

The purpose of this paper is to present the National Health Care System in the United Kingdom (UK), as it is the most representative example of the Beveridge National Health Care Model. This analysis focuses on the basic...

The level of education is the most important determinant of the perceptions of the general public about the relationship of diet to cardiovascular disease

OBJECTIVE To investigate the factors which determine the perceptions and beliefs of the general population about the relationship between diet and cardiovascular disease. METHOD A random sample of 4,799 adults from diffe...

Download PDF file
  • EP ID EP144557
  • DOI -
  • Views 91
  • Downloads 0

How To Cite

S. PAPAS, A. PAPAZAFIROPOULOU (2008). Role of incretin, incretin analogues and dipeptidyl peptidase 4 inhibitors<br /> in the pathogenesis and treatment of diabetes mellitus . Αρχεία Ελληνικής Ιατρικής, 25(5), 584-594. https://europub.co.uk/articles/-A-144557